{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:31:07Z","timestamp":1781933467019,"version":"3.54.5"},"reference-count":49,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T00:00:00Z","timestamp":1381881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Toxicol Pathol"],"published-print":{"date-parts":[[2014,7]]},"abstract":"<jats:p>Lersivirine is a nonnucleoside reverse transcriptase inhibitor (NNRTI) being developed for the treatment of HIV-1 infection. Like other NNRTIs, lersivirine is a potent enzyme inducer in rodents capable of inducing a number of hepatic enzymes including those involved in its own metabolism. Preclinically lersivirine has been associated with hepatocellular hypertrophy and thyroid gland follicular cell hypertrophy in rats, mice, and dogs. In rodents, we show that development of thyroid hypertrophy is related to the classic mechanism, namely increased thyroxine (T4) clearance secondary to induction of uridine-diphosphoglucuronosyltransferase (UDPGT) in the liver and a resulting increase in thyroid-stimulating hormone. Similarly, lersivirine-exposed dogs exhibit a significant increase in hepatic UDPGT enzyme activity along with increased T4 clearance although clear effects on serum thyroid hormone levels were less apparent. These effects on thyroid hormonal clearance in the dog suggest that thyroid gland hypertrophy in this species is due to the same mechanism shown to occur in rodents although, as expected, dogs better adapt to these effects and therefore maintain relatively normal thyroid hormonal balance. It is also notable that the minimal thyroid follicular hypertrophy that occurs in dogs does not progress as is seen in rodents. As is the case with rodents, these adaptive changes in the dog are not considered indicative of a human health risk.<\/jats:p>","DOI":"10.1177\/0192623313503516","type":"journal-article","created":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T21:01:03Z","timestamp":1382043663000},"page":"897-912","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of Lersivirine on Canine and Rodent Thyroid Function"],"prefix":"10.1177","volume":"42","author":[{"given":"Christopher D.","family":"Houle","sequence":"first","affiliation":[{"name":"Pfizer, Inc., Groton, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L.","family":"Finch","sequence":"additional","affiliation":[{"name":"Pfizer, Inc., Groton, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Mauthe","sequence":"additional","affiliation":[{"name":"Pfizer, Inc., Groton, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Potter","sequence":"additional","affiliation":[{"name":"Pfizer, Inc., Groton, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Walisser","sequence":"additional","affiliation":[{"name":"Covance Laboratories Inc., Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain B.","family":"Gardner","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Sandwich (Kent), UK"},{"name":"Simcyp, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"DeWit","sequence":"additional","affiliation":[{"name":"Pfizer, Inc, Kalamazoo, Michigan, USA"},{"name":"Southwest Michigan Innovation Center, Kalamazoo, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2013,10,16]]},"reference":[{"key":"bibr1-0192623313503516","first-page":"226","volume":"8","author":"Berruet N.","year":"2005","journal-title":"J Pharm Pharm Sci"},{"key":"bibr2-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1177\/019262339702500109"},{"key":"bibr3-0192623313503516","first-page":"823","volume-title":"Casarett and Doull\u2019s Toxicology","author":"Capen C. C.","year":"2008","edition":"7"},{"key":"bibr4-0192623313503516","first-page":"1487","volume-title":"Textbook of Veterinary Internal Medicine: Diseases of the Dog and Cat","author":"Chastain C. B.","year":"1995","edition":"4"},{"key":"bibr5-0192623313503516","first-page":"226","volume-title":"Veterinary Clinical Pathology","author":"Coles E. H.","year":"1986","edition":"4"},{"key":"bibr6-0192623313503516","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0026-895X(24)12047-0","volume":"28","author":"Collier A. C.","year":"2000","journal-title":"Drug Metabo Dispos"},{"key":"bibr7-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-12-2-135"},{"key":"bibr8-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2003.tb02467.x"},{"key":"bibr9-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(79)90099-8"},{"key":"bibr10-0192623313503516","first-page":"55","volume":"6","author":"Doniach I.","year":"1970","journal-title":"Monogr Neoplast Dis Var Sites"},{"key":"bibr11-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1080\/00401706.1969.10490658"},{"key":"bibr12-0192623313503516","first-page":"86","volume-title":"Canine and Feline Endocrinology and Reproduction","author":"Feldman E. C.","year":"2004","edition":"3"},{"key":"bibr13-0192623313503516","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0195-5616(94)50051-2","volume":"24","author":"Ferguson D. C.","year":"1994","journal-title":"Vet Clin N Am Small Ani Prac"},{"key":"bibr14-0192623313503516","first-page":"270","volume-title":"Duncan & Prasse\u2019s Veterinary Laboratory Medicine\u2014Clinical Pathology","author":"Ferguson D. C.","year":"2003","edition":"4"},{"key":"bibr15-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2885.2000.00278.x"},{"key":"bibr16-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2000.tb01167.x"},{"key":"bibr17-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/B978-044452771-4\/50014-6"},{"key":"bibr18-0192623313503516","first-page":"104","volume-title":"Current Histopathology","author":"Gresham G. A. ed.","year":"1987"},{"key":"bibr19-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-370469-6.00017-9"},{"key":"bibr20-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1080\/00498250701534893"},{"key":"bibr21-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/0272-0590(89)90001-8"},{"key":"bibr22-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/49.2.263"},{"key":"bibr23-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-5616(94)50051-2"},{"key":"bibr24-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/0016-6480(85)90108-X"},{"key":"bibr25-0192623313503516","first-page":"278","volume-title":"Contributions to Probability and Statistics","author":"Levene H","year":"1960"},{"key":"bibr26-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2004.03.002"},{"key":"bibr27-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"bibr28-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(72)80121-9"},{"key":"bibr29-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90114-7"},{"key":"bibr30-0192623313503516","volume-title":"The Toxicology Forum\u2014Annual Summer Meeting","author":"McClain R. M","year":"1986"},{"key":"bibr31-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/0027-5107(95)00139-5"},{"key":"bibr32-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(89)90004-5"},{"key":"bibr33-0192623313503516","first-page":"412","volume-title":"The Beagle as an Experimental Dog","author":"Michaelson S. M.","year":"1970"},{"key":"bibr34-0192623313503516","unstructured":"Miller R. G Jr (1980). Simultaneous Statistical Inference, 2nd ed. chap. 7, pp. 90\u201394. Springer-Verlag, New York, NY."},{"key":"bibr35-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2006.316"},{"key":"bibr36-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(20)82244-3"},{"key":"bibr37-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105831"},{"key":"bibr38-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(79)90222-7"},{"key":"bibr39-0192623313503516","first-page":"51","volume":"44","author":"Plopper C. G.","year":"1993","journal-title":"Mol Pharmacol"},{"key":"bibr40-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(87)90291-8"},{"key":"bibr41-0192623313503516","first-page":"539","volume-title":"Fundamentals of Veterinary Clinical Pathology","author":"Stockham S. L.","year":"2002"},{"key":"bibr42-0192623313503516","first-page":"311","volume-title":"Target Organ Pathology","author":"Tucker M.","year":"1998"},{"key":"bibr43-0192623313503516","unstructured":"Turner C. D. ed. (1966). General Endocrinology, 4th ed., pp. 194\u2013214. WB Saunders, Philadelphia, PA."},{"key":"bibr44-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(84)90375-7"},{"key":"bibr45-0192623313503516","unstructured":"United States Food and Drug Administration (US FDA). (1998). Efavirenz NDA 20-972, pharmacology review, summary basis of approval. Accessed August 2012. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/98\/20972pharmtox_review.pdf."},{"key":"bibr46-0192623313503516","unstructured":"US FDA. (2007). Etravirine NDA 22-187, pharmacology review, summary basis of approval. Accessed August 2012. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2008\/022187s000_PharmR_P1.pdf."},{"key":"bibr47-0192623313503516","unstructured":"US FDA. (2011). Rilpivirine NDA 202-022, pharmacology review, summary basis of approval. Accessed August 2012. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2011\/202022Orig1s000PharmR.pdf."},{"key":"bibr48-0192623313503516","doi-asserted-by":"publisher","DOI":"10.1080\/00498250902903079"},{"key":"bibr49-0192623313503516","first-page":"149","volume-title":"Statistical Principles in Experimental Design","author":"Winer B. J.","year":"1971","edition":"2"}],"container-title":["Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0192623313503516","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0192623313503516","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0192623313503516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:35:15Z","timestamp":1777653315000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0192623313503516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,16]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.1177\/0192623313503516"],"URL":"https:\/\/doi.org\/10.1177\/0192623313503516","relation":{},"ISSN":["0192-6233","1533-1601"],"issn-type":[{"value":"0192-6233","type":"print"},{"value":"1533-1601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,16]]}}}